<?xml version="1.0" encoding="UTF-8"?>
<p>There are no data regarding the behavior of COVID-19 in patients with CS. However, the metabolic and other complications associated with CS are likely to result in a poor prognosis. Diabetes and hypertension characteristically seen in CS have been identified as well-known poor prognostic factors in COVID-19 independent of age, and this may contribute to mortality among CS patients [
 <xref rid="CIT0074" ref-type="bibr">74</xref>]. These patients may be susceptible to severe pneumonia with secondary bacterial infections from changes in white blood cell count and function, reduced lymphocytes with CD4 to CD8 ratio, and reduced action of natural killer cells secondary to glucocorticoid excess [
 <xref rid="CIT0075" ref-type="bibr">75</xref>].
</p>
